Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Jun 2, 2023 00:11 UTC |
Dumont PhilippeDirector
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 10,291 | Not disclosed Strike: $4.22 | Not disclosed |
DisclosureSEC source: 0001615594-23-000041 · primary_doc.xml · derivative · entry 3 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,291 shares Expires 2031-05-27 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 00:11 UTC |
Dumont PhilippeDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 5,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000041 · primary_doc.xml · derivative · entry 2 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 00:11 UTC |
Dumont PhilippeDirector
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 5,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000041 · primary_doc.xml · derivative · entry 1 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 00:00 UTC |
Jonathan FassbergDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 32,700 | Not disclosed Strike: $0.30 | Not disclosed |
DisclosureSEC source: 0001615594-23-000040 · primary_doc.xml · derivative · entry 6 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,700 Underlying: Common Stock · 32,700 shares Expires 2032-06-13 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 00:00 UTC |
Jonathan FassbergDirector
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 32,700 | Not disclosed Strike: $0.30 | Not disclosed |
DisclosureSEC source: 0001615594-23-000040 · primary_doc.xml · derivative · entry 5 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,700 shares Expires 2032-06-13 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 00:00 UTC |
Jonathan FassbergDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 10,291 | Not disclosed Strike: $4.22 | Not disclosed |
DisclosureSEC source: 0001615594-23-000040 · primary_doc.xml · derivative · entry 4 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,291 Underlying: Common Stock · 10,291 shares Expires 2031-05-27 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 00:00 UTC |
Jonathan FassbergDirector
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 10,291 | Not disclosed Strike: $4.22 | Not disclosed |
DisclosureSEC source: 0001615594-23-000040 · primary_doc.xml · derivative · entry 3 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,291 shares Expires 2031-05-27 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 00:00 UTC |
Jonathan FassbergDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 5,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000040 · primary_doc.xml · derivative · entry 2 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 00:00 UTC |
Jonathan FassbergDirector
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 5,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000040 · primary_doc.xml · derivative · entry 1 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 23:50 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 34,900 | Not disclosed Strike: $0.30 | Not disclosed |
DisclosureSEC source: 0001615594-23-000039 · primary_doc.xml · derivative · entry 6 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,900 Underlying: Common Stock · 34,900 shares Expires 2032-06-13 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 23:50 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 34,900 | Not disclosed Strike: $0.30 | Not disclosed |
DisclosureSEC source: 0001615594-23-000039 · primary_doc.xml · derivative · entry 5 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,900 shares Expires 2032-06-13 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 23:50 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 12,761 | Not disclosed Strike: $4.22 | Not disclosed |
DisclosureSEC source: 0001615594-23-000039 · primary_doc.xml · derivative · entry 4 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,761 Underlying: Common Stock · 12,761 shares Expires 2031-05-27 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 23:50 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 12,761 | Not disclosed Strike: $4.22 | Not disclosed |
DisclosureSEC source: 0001615594-23-000039 · primary_doc.xml · derivative · entry 3 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,761 shares Expires 2031-05-27 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 23:50 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 5,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000039 · primary_doc.xml · derivative · entry 2 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 23:50 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 5,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000039 · primary_doc.xml · derivative · entry 1 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:02 UTC |
Carr Michael A.President and CEO
|
GrantStock Option (Right-to-Buy) · Derivative | 490,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · derivative · entry 5 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 490,000 shares Expires 2033-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:02 UTC |
Carr Michael A.President and CEO
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 490,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · derivative · entry 4 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 490,000 shares Expires 2033-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:02 UTC |
Carr Michael A.President and CEO
|
GrantStock Option (Right-to-Buy) · Derivative | 200,000 | Not disclosed Strike: $3.65 | Not disclosed |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · derivative · entry 3 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-07-27 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:02 UTC |
Carr Michael A.President and CEO
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 200,000 | Not disclosed Strike: $3.65 | Not disclosed |
DisclosureSEC source: 0001615594-23-000042 · primary_doc.xml · derivative · entry 2 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2031-07-27 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC |
Koschak WilliamChief Financial Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 7 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC |
Koschak WilliamChief Financial Officer
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 6 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC |
Koschak WilliamChief Financial Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 26,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 5 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC |
Koschak WilliamChief Financial Officer
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 26,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 4 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC |
Koschak WilliamChief Financial Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 110,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 3 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:35 UTC |
Koschak WilliamChief Financial Officer
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 110,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000045 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 110,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:25 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000044 · primary_doc.xml · derivative · entry 7 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:25 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000044 · primary_doc.xml · derivative · entry 6 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:25 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantStock Option (Right-to-Buy) · Derivative | 27,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000044 · primary_doc.xml · derivative · entry 5 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:25 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 27,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000044 · primary_doc.xml · derivative · entry 4 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:25 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantStock Option (Right-to-Buy) · Derivative | 80,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000044 · primary_doc.xml · derivative · entry 3 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 2, 2023 20:25 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 80,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000044 · primary_doc.xml · derivative · entry 2 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC |
Frey TravisChief Technology Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 7 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC |
Frey TravisChief Technology Officer
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 6 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC |
Frey TravisChief Technology Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 24,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 5 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC |
Frey TravisChief Technology Officer
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 24,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 4 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC |
Frey TravisChief Technology Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 80,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 3 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC |
Frey TravisChief Technology Officer
|
Disposition to issuerStock Option (Right-to-Buy) · Derivative | 80,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| February 07, 2023 Filed Feb 8, 2023 16:59 UTC |
Koschak WilliamChief Financial Officer
|
OtherCommon Stock | 23,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000007 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,774 F1 · kind: Shares transferred to reporting person's ex-spouse pursuant to a divorce decree. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 16:44 UTC |
Carr Michael A.President and CEO
|
Tax withholdingCommon Stock | 47,877 | $0.15 | $7,061.86 |
DisclosureSEC source: 0001615594-23-000005 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,064 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 16:35 UTC |
Koschak WilliamChief Financial Officer
|
Tax withholdingCommon Stock | 42,570 | $0.15 | $6,279.08 |
DisclosureSEC source: 0001615594-23-000002 · primary_doc.xml · nonDerivative · entry 1 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,525 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 16:38 UTC |
Frimerman Debra HGeneral Counsel and Secretary
|
Tax withholdingCommon Stock | 35,724 | $0.15 | $5,269.29 |
DisclosureSEC source: 0001615594-23-000003 · primary_doc.xml · nonDerivative · entry 1 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,224 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:41 UTC |
Frey TravisChief Technology Officer
|
Tax withholdingCommon Stock | 37,573 | $0.15 | $5,542.02 |
DisclosureSEC source: 0001615594-23-000004 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,304 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| September 19, 2022 Filed Sep 20, 2022 16:09 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 30,000 | $0.24 | $7,173.00 |
DisclosureSEC source: 0001615594-22-000049 · primary_doc.xml · nonDerivative · entry 1 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,225 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on September 21, 2021. F2 · shares: The price reported in Column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $.2300 to $.2506, inclusive. Read SEC document |
| July 27, 2022 Filed Jul 28, 2022 17:18 UTC |
Carr Michael A.Director · President and CEO
|
Tax withholdingCommon Stock | 4,059 | $0.22 | $892.98 |
DisclosureSEC source: 0001615594-22-000045 · primary_doc.xml · nonDerivative · entry 1 Carr Michael A. · CIK 0001875512 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,941 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:07 UTC |
Nelson Kimberly K.Director
|
GrantStock Option (Right-to-Buy) · Derivative | 37,100 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001615594-22-000034 · primary_doc.xml · derivative · entry 2 Nelson Kimberly K. · CIK 0001489097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,100 Underlying: Common Stock · 37,100 shares Expires 2032-06-13 F1 · derivative.exercise_date: Option vests in full on the first anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 16:19 UTC |
Ribeill Yves JDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 47,200 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001615594-22-000038 · primary_doc.xml · derivative · entry 2 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,200 Underlying: Common Stock · 47,200 shares Expires 2032-06-13 F1 · derivative.exercise_date: Option vests in full on the first anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 16:04 UTC |
NEUGENT CHRISTOPHER JDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 36,400 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001615594-22-000033 · primary_doc.xml · derivative · entry 3 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,400 Underlying: Common Stock · 36,400 shares Expires 2032-06-13 F2 · derivative.exercise_date: Option vests in full on the first anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:16 UTC |
Jonathan FassbergDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 32,700 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001615594-22-000037 · primary_doc.xml · derivative · entry 2 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,700 Underlying: Common Stock · 32,700 shares Expires 2032-06-13 F1 · derivative.exercise_date: Option vests in full on the first anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:13 UTC |
Dumont PhilippeDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 32,700 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001615594-22-000036 · primary_doc.xml · derivative · entry 2 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,700 Underlying: Common Stock · 32,700 shares Expires 2032-06-13 F1 · derivative.exercise_date: Option vests in full on the first anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:10 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 34,900 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001615594-22-000035 · primary_doc.xml · derivative · entry 2 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,900 Underlying: Common Stock · 34,900 shares Expires 2032-06-13 F1 · derivative.exercise_date: Option vests in full on the first anniversary of the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.